Assaying the Potency of Influenza Vaccines - Wikidata - wikimedia - TriplyDB

Assaying the Potency of Influenza Vaccines

Assaying the Potency of Influenza Vaccines

http://www.wikidata.org/entity/Q26783499

about

Cross-Neutralising Nanobodies Bind to a Conserved Pocket in the Hemagglutinin Stem Region Identified Using Yeast Display and Deep Mutational Scanning.Application of recombinant hemagglutinin proteins as alternative antigen standards for pandemic influenza vaccines.Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies Impact of Aging and Cytomegalovirus on Immunological Response to Influenza Vaccination and Infection.Standardisation of inactivated influenza vaccines-Learning from history.Potency determination of inactivated H7 influenza vaccines using monoclonal antibody-based ELISA and biolayer interferometry assays.Principles of vaccine potency assays.An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations.VaxArray potency assay for rapid assessment of "pandemic" influenza vaccines Assessment of potency of inactivated Newcastle disease oil-adjuvanted vaccines using hemagglutination test and blocking ELISA

P2860

Q30394097-428A0BDB-DDEE-479F-ADCC-0592EC0BF479 Q30403029-E185F153-1785-49B4-9E84-7B3EDE03569D Q36350940-F9E8239F-AA95-4D8D-ACCC-5E489E17046C Q39310460-181C574A-48DB-468D-AA38-76E83466E4A3 Q47550493-E3A8098C-49EF-47CC-9741-640A57F324F9 Q47575744-14D8B3BB-DFBF-441E-8825-18F90D7DC6CD Q50047834-64D2CF8F-DBAE-4D58-9E23-92768464EE3A Q52607528-FD7ED646-A182-499F-9A3E-D0D8E6941380 Q57481875-227F0F33-CA01-4869-BD1E-E4DD4CB522A5 Q58562964-1B35C291-9238-4B3B-96AF-3CD6916A3B61

P2860

Assaying the Potency of Influenza Vaccines

http://www.wikidata.org/entity/Q26783499

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

Assaying the Potency of Influenza Vaccines

@ast

Assaying the Potency of Influenza Vaccines

@en

Assaying the Potency of Influenza Vaccines

@nl

type

label

Assaying the Potency of Influenza Vaccines

@ast

Assaying the Potency of Influenza Vaccines

@en

Assaying the Potency of Influenza Vaccines

@nl

prefLabel

Assaying the Potency of Influenza Vaccines

@ast

Assaying the Potency of Influenza Vaccines

@en

Assaying the Potency of Influenza Vaccines

@nl

P1433

Q26783499-9F4366BE-F427-447D-94F6-C573803E66D3

P1476

Q26783499-C114A2C5-DE24-476C-B393-0DE9F197DA26

P2093

Q26783499-60BBCF06-9682-4FC7-9344-B8861F59C93D

P2860

Q26783499-0C5EB684-5623-40BD-B9F5-2B5856261719

Q26783499-172E86B6-8C44-4FD7-941D-4D39237BD653

Q26783499-2017D332-3DA0-4CF2-8054-0739F4F86A16

Q26783499-2A7886CE-FB1B-4EF0-8C9D-2C3E718EF29A

Q26783499-2B5BD319-46E2-4B59-8F5B-F127A4DBBCE5

Q26783499-5449B837-F0DE-4A54-A91E-D39E91FE85A4

Q26783499-54CC0D43-B084-4799-B8E4-993594521A6D

Q26783499-7065D852-9E9C-4182-BB97-BBA0B5A512CC

Q26783499-7C415768-AF8B-407C-A462-A3A2F567B5E0

Q26783499-83B0D1D8-FEBC-4F59-AE37-C869D17A5EBD

P304

Q26783499-3CA0D928-30EB-41FD-9E4B-32E2B740F889

P31

Q26783499-07E1DC88-479A-41CF-A6F4-F64DD7F8879E

P3181

Q26783499-8E67744E-DB7D-4408-973F-7E9859EA1838

P356

Q26783499-627DB43A-68CE-4F5B-A316-89B9EABECC1C

P407

Q26783499-4A68BEC9-0CE3-4AC1-99C8-B5A3CA1722E5

P433

Q26783499-55EFB643-EEB5-4168-AD4D-7FCE71CF7D1A

P478

Q26783499-EF2BB313-B5EE-494E-A30B-2BBFFE0DD73A

P577

Q26783499-B90CA3A4-D86E-4697-B892-3E9CE2C9DBBC

P5875

Q26783499-2E0F2C6B-7F68-4A1E-90A3-15C33163B87F

P698

Q26783499-0D1A376C-77B3-48D1-BD16-7CA592401D08

P932

Q26783499-EA188870-6E96-409E-841E-5C40C1DF185D

P3181

P356

VACCINES3010090

P1433

P1476

Assaying the Potency of Influenza Vaccines

@en

P2093

Philip D Minor

http://www.w3.org/2001/XMLSchema#string

P2860

A highly conserved neutralizing epitope on group 2 influenza A viruses

Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials.

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

Novel antibody-independent receptor-binding SPR-based assay for rapid measurement of influenza vaccine potency.

The breadth of cross sub-type neutralisation activity of a single domain antibody to influenza hemagglutinin can be increased by antibody valency.

A monoclonal antibody-based immunoassay for measuring the potency of 2009 pandemic influenza H1N1 vaccines.

Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry.

Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children.

Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: safety and immunogenicity of a phase 1/2 clinical trial.

Optimization and qualification of a quantitative reversed-phase HPLC method for hemagglutinin in influenza preparations and its comparative evaluation with biochemical assays.

P304

90-104

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2975422

http://www.w3.org/2001/XMLSchema#string

P356

10.3390/VACCINES3010090

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272386548

http://www.w3.org/2001/XMLSchema#string

P698

26344948

http://www.w3.org/2001/XMLSchema#string

P932

4494238

http://www.w3.org/2001/XMLSchema#string